Skip to main content
. 2014 Mar 17;9(3):e90710. doi: 10.1371/journal.pone.0090710

Figure 1. Prevalence of TDR (WHO SDRM estimates) by antiretroviral class between 2007 and 2011.

Figure 1

NRTI: nucleoside reverse transcriptase inhibitors; NNRTI: non-nucleoside reverse transcriptase inhibitors; PI: protease inhibitors. * p value for Chi-square test for trend.